BioMerieux has launched Nuclisens EasyQ MRSA, an automated test for Methicillin Resistant Staphylococcus Aureus (MRSA).
The test rapidly detects seven MRSA types, covering the most prevalent strains, with a turnaround time of less than three hours and the flexibility for batch (46 tests) or standalone (one test) screening.
With simultaneous detection of two targets, the Nuclisens EasyQ System reduces the risk of false positive results, improves specificity and avoids re-testing and inappropriate antibiotic treatment or isolation of patients.
Nuclisens EasyQ MRSA is CE marked and more molecular tests for resistant bacteria, like VRE and C difficile, are planned for the platform in the future.
Influenza A/B, HIV viral load, HSV 1+2 and RSV A+B are among the tests already available.
